US Patent 8846104 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Actavis Inc

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Contact Supplier

Axplora is your partner of choice for complex APIs.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-2-2026-02-09

Actavis Inc

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 415 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
415 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

108 All APIs, 103 USDMF, 7 CEP/COS, 1 JDMF, 5 NDC API, 1 VMF

108 All APIs
103 USDMF
7 CEP/COS
1 JDMF
5 NDC API
1 VMF

DEVELOPMENTS

211 Drugs in Development

211 Drugs in Development

FINISHED DOSAGE FORMULATIONS

2802 FDF Dossiers, 2337 FDA Orange Book, 439 Europe, 2 Australia, 24 South Africa

2802 FDF Dossiers
2337 FDA Orange Book
439 Europe
2 Australia
24 South Africa

EXCIPIENTS

1 All Excipients, 1 USDMF

1 All Excipients
1 USDMF

REF. STANDARDS & IMPURITIES

1 Others

1 Others

INSPECTIONS & REGISTRATIONS

145 FDA, 31 EDQM, 14 GDUFA, 3 Third-Party Audit

145 FDA
31 EDQM
14 GDUFA
3 Third-Party Audit

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 6ALPHARMA PHARMS

filter Patent Number Reset all filters

6 All

01 68846104

API Patent Reset all filters

6 All

01 6Blank

filter FDF Patent Reset all filters

6 All

01 6Y

filter Expiration Date Reset all filters

6 All

01 62027-06-19

01

ALPHARMA PHARMS

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

BePharma

Not Confirmed

ALPHARMA PHARMS

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-19

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

US Patent Number : 8846104

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22321

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-06-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ALPHARMA PHARMS

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

BePharma

Not Confirmed

ALPHARMA PHARMS

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-19

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

US Patent Number : 8846104

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22321

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-06-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ALPHARMA PHARMS

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

BePharma

Not Confirmed

ALPHARMA PHARMS

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-19

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

US Patent Number : 8846104

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22321

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-06-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

ALPHARMA PHARMS

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

BePharma

Not Confirmed

ALPHARMA PHARMS

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-19

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

US Patent Number : 8846104

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22321

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-06-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

ALPHARMA PHARMS

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

BePharma

Not Confirmed

ALPHARMA PHARMS

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-19

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

US Patent Number : 8846104

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22321

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-06-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

ALPHARMA PHARMS

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

BePharma

Not Confirmed

ALPHARMA PHARMS

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-19

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

US Patent Number : 8846104

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22321

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-06-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.